KeyCorp KEY
$19.45 −$0.58 (-2.90%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $19.62 +0.87%
Open$20.08
Prev close$20.03
Day range$19.39 – $20.23
Volume21.38M
Market cap$20.54B
P/E (TTM)10.7
Dividend yield4.22%
KEY Stock News
Headlines matching KeyCorp or the KEY ticker, most recent first.
- Morgan Stanley Maintains KeyCorp(KEY.US) With Hold Rating, Maintains Target Price $25
- Keyera Corp. (KEY) Receives a Buy From Jefferies
- Stifel Nicolaus Remains a Hold on Keyera Corp. (KEY)
- Citi Sticks to Their Buy Rating for Keyera Corp. (KEY)
- Hangya Technology (688510.SH): The company is a key participant in the concurrent research and development of critical components for domestic aero-engines.
- Citi: Raises Hengrui Pharma's target price to HK$120 and remains one of its key recommendations. Positive
- Notice by Wan Jia Fund Management Co., Ltd. Regarding the Update of the Prospectuses and Key Facts Statements for Its Publicly Offered Mutual Funds
- On September 29, 2026, the company held its 2026 interim results briefing via the SSE Roadshow Center of the Shanghai Stock Exchange, engaging with investors to address their key concerns.
- Notice by Wan Jia Fund Management Co., Ltd. Regarding the Update of the Prospectuses and Key Facts Statements for Its Publicly Offered Mutual Funds
- Truist Financial Maintains KeyCorp(KEY.US) With Hold Rating, Announces Target Price $23
- Citi Initiates KeyCorp(KEY.US) With Hold Rating, Announces Target Price $22
- Barclays Maintains KeyCorp(KEY.US) With Hold Rating, Maintains Target Price $24
- Goldman Sachs Maintains KeyCorp(KEY.US) With Buy Rating, Maintains Target Price $27
- Barclays Sticks to Its Hold Rating for Keyera Corp. (KEY)
- Barclays Maintains KeyCorp(KEY.US) With Hold Rating, Maintains Target Price $24
No comments yet — be the first to weigh in on KEY.
Sign in to join the discussion.